IL33 and cancer: Conversely, 28 pathways in the KO_IL-25/IL-33 transcriptomes were associated with cytokine–cytokine receptor interaction, pathway in cancer, glutathione metabolism, purine, and pyrimidine as well as Ras/Rap1 signaling (Fig. 3C–D).